Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

QGEN

Qiagen NV (QGEN)

Qiagen NV
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:QGEN
DateTimeSourceHeadlineSymbolCompany
05/02/20244:05PMGlobeNewswire Inc.QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsNYSE:QGENQiagen NV
04/29/20244:05PMGlobeNewswire Inc.QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceNYSE:QGENQiagen NV
04/24/20244:05PMGlobeNewswire Inc.QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceNYSE:QGENQiagen NV
04/09/20249:48AMGlobeNewswire Inc.QIAGEN N.V. to release results for Q1 2024 and hold webcastNYSE:QGENQiagen NV
04/03/20244:05PMGlobeNewswire Inc.QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024NYSE:QGENQiagen NV
03/25/20244:05PMGlobeNewswire Inc.QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemNYSE:QGENQiagen NV
03/18/20244:05PMGlobeNewswire Inc.QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsNYSE:QGENQiagen NV
03/11/20245:59AMGlobeNewswire Inc.QIAGEN announces Form 20-F annual report filing for 2023 resultsNYSE:QGENQiagen NV
02/27/20245:44PMGlobeNewswire Inc.QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discoveryNYSE:QGENQiagen NV
02/27/20244:05PMGlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
02/15/20244:05PMGlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
02/08/20249:47AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
02/06/20244:05PMGlobeNewswire Inc.QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitabilityNYSE:QGENQiagen NV
01/25/202410:00AMGlobeNewswire Inc.QIAGEN announces partnership with Penn State University to advance microbiome sciencesNYSE:QGENQiagen NV
01/23/20244:13PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:QGENQiagen NV
01/18/20244:05PMGlobeNewswire Inc.QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 millionNYSE:QGENQiagen NV
01/11/20247:53AMGlobeNewswire Inc.QIAGEN N.V. to release results for Q4 2023 and hold webcastNYSE:QGENQiagen NV
01/08/20249:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
01/08/20242:00AMGlobeNewswire Inc.QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular SystemsNYSE:QGENQiagen NV
01/07/20241:07PMGlobeNewswire Inc.QIAGEN announces plans to return approximately $300 million to shareholdersNYSE:QGENQiagen NV
01/04/20244:05PMGlobeNewswire Inc.QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics businessNYSE:QGENQiagen NV
01/03/20242:00AMGlobeNewswire Inc.QIAGEN expands business in Middle East with new regional headquarters and major projectsNYSE:QGENQiagen NV
11/30/20234:05PMGlobeNewswire Inc.DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogyNYSE:QGENQiagen NV
11/15/20234:05PMGlobeNewswire Inc.QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolationNYSE:QGENQiagen NV
11/09/20234:05PMGlobeNewswire Inc.QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customersNYSE:QGENQiagen NV
11/06/20234:05PMGlobeNewswire Inc.QIAGEN launches complete Sample to Insight workflow for microbiome researchNYSE:QGENQiagen NV
11/02/20238:00AMPR Newswire (US)QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
11/02/20238:00AMGlobeNewswire Inc.QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
10/30/20234:05PMGlobeNewswire Inc.QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CERNYSE:QGENQiagen NV
10/26/20238:00AMGlobeNewswire Inc.QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancerNYSE:QGENQiagen NV
 Showing the most relevant articles for your search:NYSE:QGEN